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ABSTRACT 
 
  Changes in intracellular calcium concentration are crucial events during signal 
transduction processes involved in several cellular physiological functions. Moreover, 
even a limited dysregulation in intracellular calcium homeostasis can promotes the onset 
and the progression of neuropathological processes. We have shown previously that the 
olive pomace extract, obtained in condition of high pressure and high temperature 
(HPTE), contains bioactive molecules able to prevent calcium-induced cell damages on 
human neuroblastoma (SK-N-BE) and mouse brain endothelioma (bEnd5) cell lines, 
operating through the regulation of the cell dynamics that involve the calcium ions. 
In this thesis, we report the effect of HPTE on primary cell culture of murine cortical 
neurons used as a cellular model. Specifically, in order to induce a cytotoxic influx of 
Ca2+ through the opening of the NMDA (N-Methyl-D-Aspartic-Acid) receptor 
(NMDAR), we treated neurons with NMDA in the presence or in the absence of HPTE 
for 24 hours. We demonstrate that HPTE 1) significantly reduces the cytotoxic effect of 
NMDA, evaluated as percentage of cell death, and 2) operates preventing the increase 
of the intracellular calcium concentration mediated by the NMDAR. 
To identify the chemical nature of the active factors in the olive pomace extract, we 
have fractionated HPTE by RP-HPLC, followed by the assay of the cell protective 
effect. Successively, on the fractions containing the bioactivity and using mass 
spectrometry techniques, we established that the relevant molecules could be derivatives 
of the epigallocatechin or of the loganin.  
The ultimate aim of this work is to provide new information about the structural and 
functional specificity of molecules present in the HPTE in order to propose new 
possible strategies for therapeutic interventions in neurodegenerative diseases.
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1. INTRODUCTION 
1.1. Extra virgin olive oil in Mediterranean diet  
Growing evidence shows that a dietary pattern inspired by Mediterranean Diet (MD) 
principles is associated with numerous health benefits. A Mediterranean-type diet has 
been demonstrated to exert a preventive effect toward cardiovascular diseases, in both 
Mediterranean and non-Mediterranean populations. These properties may in part 
depend on the positive action on the cardiometabolic risk, by decreasing the risk of 
diabetes and metabolic-related diseases. There is also evidence of a potential role of the 
MD in preventing certain cancers. A high adherence to the MD has been associated 
with a slower cognitive decline, with reduced risk of mild cognitive impairment 
conversion to Alzheimer's disease (AD) and with reduced risk of AD [1]. 
Older adults appear to be at high risk for cognitive impairment and the increased life 
expectancy observed in developed countries is accompanied by increasing prevalence of 
dementia and of its major cause, Alzheimer's disease. Among lifestyle-relate factors 
recently proposed as the first line of defense against the development and progression 
of cognitive impairment, nutrition constitutes an interesting approach. Beyond the 
potential impact of specific nutrients such as antioxidants, n-3 polyunsaturated fatty 
acids (PUFA) and homocysteine-related vitamins (vitamin B12 and folate), dietary 
patterns allow to investigate their additional synergistic effects [1]. 
Most nutrients that have been individually associated with prevention of cognitive 
decline in preclinical or epidemiological studies are present in the MD: MUFA 
(monounsaturated fatty acids), found in large amounts in olive oil, long-chain n-3 
PUFA, mainly provided by fish and seafood, vitamins B12, folate, and antioxidants 
(vitamins C and E, carotenoids, flavonoids and selenium) from plant foods.  
The MD is characterized by abundant consumption of plant foods such as fresh fruits, 
vegetables, bread, other forms of cereals, potatoes, beans, nuts and seeds; extra virgin 
olive oil (EVOO) as the main source of fats, providing notably monounsaturated lipids; 
a low-to-moderate intake of dairy products in the form of cheese and yogurt; a low-to-
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moderate consumption of fish depending of the proximity of the sea; a low-to-moderate 
consumption of poultry; low amount of red meat and wine consumed in low-to-
moderate amounts, normally during meals [2]. 
Olea Europea L. is a fruit tree native to Asia Minor and Syria, which today is cultivated 
in the entire Mediterranean area; nowadays, the major producers of olives and olive oil 
are Spain, Italy and Greece. EVOO, physically extracted from the fruit, is known for its 
nutritional properties and health effects. These properties are due to the presence of 
high levels of fatty acids (98-99% of the total weight of EVOO), in particular of 
monounsatured acids such as oleic, as well as of other valuable components like 
phenolics, phytosterols, tocopherols, and squalene even if present in low percentages (1-
2%). Only EVOO, and not all seed oils, has a high percentage of fatty acids with a 
correct balance of unsaturated fatty acids stabilized by minor polar compounds, with 
antioxidant character. Among the minor components, the phenolic ones are relevant for 
the health effects attributed to EVOO and are the main antioxidants found in virgin 
olive oil, which contains both hydrophilic and lipophilic phenols. The main phenolic 
subclasses present in olive oil are phenolic alcohols, phenolic acid, flavonoids, lignans 
and secoiridoids. Despite their low concentration, they are responsible for numerous 
health effects in humans [3]. 
The chemical characteristics, functional or medical food properties, biological and 
biomedical activities of these compounds have been described to demonstrate how the 
olive tree can be considered a food species of great scientific and health interest. Recent 
circular economy models, promoting green technologies for the recovery of active 
compounds from by-products and waste, have been already established in the olive oil 
industry. Biological and biomedical activities of many secondary metabolites from Olea 
Europaea L. have been scientifically proven. For this reason, the olive tree is an 
unmatched sustained resource for unique bioactive compounds with diverse health 
benefit [3].  
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1.2. Recovery of phenolic compounds present in olive oil 
by-product  
By-products from olive oil production are the starting material to obtain bioactive 
compounds by green technologies. Olive tree cultivation is particularly widespread in 
the Mediterranean basin and provides a strong contribution as a source of polyphenols. 
After the production of olive oil, the large quantities of olive pulp and olive oil waste-
waters obtained as by-products represent a great environmental problem given their 
high toxicity. Olive oil by-products, such as olive mill and leave waste are allowed for 
production of feed, cosmetics, food, and nutraceuticals, whereas olive oil waste-waters 
are only allowed for use in agronomy [3]. 
Although the high phenol, lipid and organic acid content its responsible for 
phytotoxicity, olive mill waste also contains valuable resources such as a great amount 
of interesting phytochemicals that could be recovered. Indeed, although the olive fruit is 
very rich in phenolic compounds, the largest portion of these compounds is lost in the 
olive mill by-products during the milling process. In particular, phenolic fraction in oil is 
below 2% of the total phenolic content of the olive fruits, with the remaining 98% 
being lost in olive mill waste. These huge quantities of olive mill by-products are 
potential rich sources of phenol compounds, endowed with a wide array of biological 
activities [4]. 
Currently, EVOO can be obtained by two main milling processes: the three-phase 
system, which is widely used in Italy, Greece and other Mediterranean countries; and the 
two-phase system, which is mainly used in Spain. In the first case, olive oil is separated 
from two other by-products, olive mill waste-water and a solid olive residue (olive 
pomace) whereas, in the latter system, only a semi-solid waste containing both water 
and solid residue is obtained. The production of large quantities of these by-products, 
especially in the 3-4 months of intensive olive oil production, and the variability of the 
waste composition are the main problems in residue management, even today [4]. 
Olive pomace can reach up to 30% of olive oil manufacturing, depending on the 
milling process, which, after oil extraction, is generally distributed by means of 
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controlled spreading in agricultural soil. This solid waste is of heterogeneous nature and 
contains many chemical compounds, such as alkaline (potassium) and alkaline earth 
(calcium and magnesium) metals, sugars and polyphenols. Since polyphenols are 
bioactive compounds with antioxidant, neuro-sedative, anti-inflammatory, anti-viral and 
anti-cancer properties, olive pomace can be considered an interesting source of phenolic 
compounds [3]. 
The disposal of by-products of the olive oil industry creates a major environmental 
problem in the main olive-producing countries. Therefore, a suitable use of these olive 
residues could not only improve the economic status of olive oil producers, but could 
also reduce an environmental problem. Thus, it is of great interest to evaluate the 
possibility of recovering an extract enriched with phenolic compounds, from a low-cost 
and widely available by-product, especially in the Mediterranean area [4]. 
An innovative extraction technique exploits the performance of a high pressure-high 
temperature (HPHT) reactor for the phenolic extraction from olive pomace. High 
temperatures decrease the viscosity of liquid solvents, thus allowing better penetration 
of matrix particles and enhancing extraction. Increased temperatures can also disrupt 
the strong solute-matrix interactions caused by van der Waals forces, hydrogen bonding, 
and dipole attractions between the solute molecules and the active sites on the matrix. 
The high pressure should facilitate extraction of the analytes trapped in matrix pores. 
Indeed, the pressure forces the solvent into areas of the matrices that would not 
normally be reached by solvents under atmospheric conditions. The purpose of 
pressurizing the extraction cell is to prevent the solvent from boiling at the extraction 
temperature and to ensure that the solvent remains in intimate contact with the sample 
throughout the extraction time, granting a higher solubility to the molecules and 
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1.3. Protective effect of phenol compounds on 
neurodegenerations  
Neurodegenerative diseases represent a heterogeneous group of disorders that share 
common features like abnormal protein aggregation, perturbed Ca2+ homeostasis, 
excitotoxicity, impairment of mitochondrial functions, apoptosis, inflammation, and 
oxidative stress. Despite recent advances in the research of biomarkers, early diagnosis 
and pharmacotherapy, there are no treatments that can halt the progression or reverse 
the brain changes of any age-associated neurodegenerative disease nowadays. This is 
likely due to the multifactorial nature of these pathologies that arise from a confluence 
of multiple toxic insults [6]. Furthermore, these diseases are associated with a high 
morbidity and mortality and represent a primary health problem especially in the aging 
population [7]. 
In excitotoxic conditions, mitochondrial dysfunction associated with altered Ca2+ 
homeostasis and enhanced cellular oxidative stress, plays a major role in cell damage [8]. 
Excitotoxicity is involved in the pathogenesis of several central nervous system 
disorders, including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's 
disease and the AIDS dementia complex. This process can occur through over-
activation of the N-Methyl-D-Aspartate receptor (NMDAR), with subsequent influx of 
Ca2+, activation of both neuronal nitric oxide synthase (nNOS) and inducible nitric 
oxide synthase (iNOS), and excessive generation of nitric oxide (NO) [8]. 
Under these circumstances, stimulation of ionotropic glutamate receptors causes 
massive Ca2+ entry and is highly involved in the process of neuronal death. Energy 
depletion and increased oxidative damage affect the function of several synaptic 
proteins such as Na+, K+-ATPase and may result in a loss of local Ca2+ homeostasis and 
depolarization of the plasma membrane. Consequently, synaptic degeneration occurs. In 
addition, the increase of cytosolic Ca2+ concentration promotes the activation of several 
intracellular enzymes that can elicit generation of endogenous reactive oxygen species 
(ROS). Moreover, an increase in mitochondrial Ca2+ can also promote ROS generation, 
and intracellular Ca2+ overload associated with excitotoxicity can induce both apoptosis 
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and necrosis [7]. Therefore, elevation of intracellular Ca2+ and increased ROS 
production are the major causes of neuronal death in excitotoxicity [9]. 
In the recent years, many studies have been focused on natural phytocomponents 
present in food as important bioactive molecules against age-related chronic illnesses as 
neurodegenerative diseases [10] [11]. A large body of evidence supports the beneficial 
effects of the MD in preventing neurodegenerations, possibly due to its richness in 
phenols content. Furthermore, natural phenols are able to modulate the redox state of 
cells through direct action on enzymes, receptors, and different signaling pathways [7]. 
Recent papers have demonstrated the beneficial effects of polyphenols on the 
regulation of Ca2+ dynamics, such as the protective effect of oleuropein and its 
metabolite hydroxytyrosol in the dysregulation of Ca2+ dynamics occuring via T-type 
Ca2+ channels [12], or the protective activity of quercetin against mythocondrial 
dysfunction and cell death caused by the increase in the [Ca2+]i  [13]. 
However, flavonoids have been proposed to play a useful role in protecting central 
nervous system against oxidative and excitotoxic stress [14]. In addition to the 
antioxidant properties of the natural phytochemicals, the inhibitory effect exerted by 
some of these compounds on specific excitotoxic processes, such as Ca2+ influx, 
provides additional evidence for the potential beneficial health effects of polyphenols on 
excitable tissues, particularly the central nervous system [15]. 
1.4. Excitotoxicity and overactivation of NMDA receptor 
The excitatory amino acids (EAAs) primarily L-glutamate (Glu), L-aspartate (Asp) and 
related derivatives, act through multiple classes of receptors that are located on virtually 
all neurons in the vertebrate CNS. Receptors for EAAs belong to two major categories: 
metabotropic and ionotropic receptors. Ionotropic receptors control ion channels, 
whereas metabotropic receptors are coupled to G proteins. The mammalian family of 
ionotropic glutamate receptor encodes 18 gene products that form ligand-gated ion 
channels containing an agonist recognition site, a transmembrane ion permeation 
pathway, and gating elements that couple agonist-induced conformational changes to 
the opening or closing of the permeation pore. The glutamate ionotropic receptors 
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mediate fast excitatory synaptic transmission in the central nervous system but they are 
also localized on non-neuronal cells and regulate a broad spectrum of processes in brain, 
spinal cord, retina, and peripheral nervous system. These integral membrane receptors 
are composed of four large subunits (>900 amino acid residues) that form a central ion 
channel pore. Sequence similarity among different ionotropic glutamate receptor 
subunits, including the AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid), 
kainate, NMDA (N-Methyl-D-Aspartate) and δ-receptors; suggest that they share a 
similar architecture [16]. 
NMDAR, one of the ionotropic glutamate receptors, consists of several distinct 
recognition sites. The primary neurotransmitter binding-site can interact with Asp, Glu 
and the Asp analog NMDA that acts as a selective agonist for this glutamate receptor. 
The other sites include: 1) a cation channel that permits the conductance of calcium and 
sodium, 2) a voltage-dependent site that binds magnesium and, at resting membrane 
potential, blocks channel conductance, 3) a co-agonist site that binds glycine (Gly), 4) an 
inhibitory site that binds phencyclidine (PCP), ketamine, MK-801 and other non-
competitive antagonists, and 5) an allosteric modulatory site that recognizes polyamines 
[17]. The molecular structure of NMDAR shows a heterotetrameric assembly, that 
typically contains two NR1 subunits and other two subunits including NR2 (A, B, C & 
D) or NR3 (A & B) variants. The various combination of NR2 subunits produce 
multiple subtypes of NMDAR. NR2A- and NR2B-containing receptors generate high 
conductance opening, whereas NR2C- and NR2D-containing receptors have low 
conductance opening. Expression of the NR2 subunits varies across different brain 
regions, developmental stages and physiological responses to environmental stimulation. 
Meanwhile, NR2 subtypes provide different physiological function. Over activation or 
upregulation of NR2B seems involved in neurological diseases including stroke, 
ischemia, chronic pain, Alzheimer's disorder and Huntington's disease. In agreement 
with these observations, NR2B-selective antagonists display protective effects against 
these diseases in animal models. NR2C- and NR2D-containing NMDARs are critical 
for ischemia-induced myelin damage that is prevented by NR2C/D antagonists. 
Essentially, selective NMDAR antagonists for distinct subtypes have more efficient 
therapeutic and lower side effects for specific neurological disorders compared to non-
selective NMDAR antagonists [16]. 
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Activation of the NMDAR results in an influx of Ca2+ that acts as a second messenger 
in the regulation of neurotransmitter release, synaptic plasticity and gene expression. In 
addition to stimulating physiological intracellular events, the excessive activation of 
these receptors may damage the neuron, causing excitotoxic cell death. This 
phenomenon seems a common outcome following brain insults of different origin, such 
as trauma, epileptic seizures and cerebral ischemia. The excitotoxic process is primarily 
mediated by elevated concentrations of intracellular Ca2+ and ROS and it can be 
manifested as apoptosis or necrosis [18]. 
 Glutamate-induced excitotoxicity, caused by an excessive cell exposure to glutamate 
or to excitatory concentrations of NMDA, leads to influx of Ca2+ through the NMDA 
subtype receptor, triggering the generation of NO and superoxide anions, and altering 
the regulation of gene expression, with the final result of cell death. Indeed, excessive 
stimulation of the NMDAR is implicated in the development of several neurological 
diseases such as stroke, Alzheimer's disease and depression. Therefore, NMDAR is an 
important pharmacological target for the treatment of neurological diseases and 
disorders [19]. 
1.5. Activation of proteolytic calcium-dependent enzyme 
calpain-1  
A rise in the ([Ca2+]i) has been identified as a primary trigger of  different pathologies. 
Ca2+-dependent processes, which represent points of convergence among a 
heterogeneous set of degenerative mechanisms, are therefore logical targets for 
intervention strategies, and have the potential to generate valuable markers of 
pathogenesis [20]. 
Pathological activation of NMDARs, with consequent alteration in intracellular 
calcium homeostasis, determines the activation of several protein such as calpain-1 a 
ubiquitous calcium-dependent cysteine protease that plays a key role in cell survival [20]. 
Calpains are a group of intracellular endopeptidases present in almost all eukaryotes 
and bacteria, but not in archaeabacteria. In humans, this group of enzymes includes 15 
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isoforms, some of which are present ubiquitously and other ones show a tissue-specific 
pattern of expression [21]. Calpains operate in many pathological and physiological 
processes such as cytoskeletal remodeling, cell proliferation, migration, invasion, 
apoptosis and signal transduction [21] [22]. Following activation, calpains can catalyze 
the proteolytic processing of a large number of intracellular proteins leading to 
modification of cell behavior and viability. Because these enzymes are involved not only 
in normal intracellular signal transduction cascades, but also in various aberrant 
pathways, investigations on the molecular mechanisms for the control of calpain activity 
has aroused great interest in wide areas of life sciences in both basic and clinical research 
in the last decades [23]. Calpains show peculiar functional properties not overlapping to 
those played by the ubiquitin-proteasome system, the autophagy-lysosomal system and 
the caspases. First of all, the digestion of the substrates mediated by calpains generally 
occurs in a limited and selective manner. Since the target protein does not undergo 
extensive degradation but often acquires novel functional properties, this irreversible 
protein modification has been termed "proteolytic processing". Furthermore, calpains 
do not require any protein modification or tag to recognize and hydrolyze the 
susceptible peptide bonds present in the consensus sequences of their substrates [22]. 
The conventional members in the superfamily of calpains are heterodimers consisting 
of different 80 kDa catalytic large L-subunits and 30 kDa regulatory small S-subunits. 
Calpain-1 and calpain-2, are the best characterized isozymes of the calpain family. These 
heterodimers share the same 30 kDa regulatory subunit, but each one has a different 80 
kDa catalytic subunit. These two calpains are ubiquitous (with the exception of 
erythrocytes that lack calpain-2) and are distinguished by the calcium requirement to 
undergo in vitro activation. Indeed, calpain-1 (also known as μ-calpain) needs 5-20 μM 
Ca2+, while calpain-2 (also known as m-calpain) needs 400-800 μM Ca2+[22]. The 
catalytic subunits of calpain-1 and calpain-2 contain four domains/regions: the N-
terminal anchor helix region, the CysPc Protease Core Domain (PC1 and PC2), the C2 
like domain (C2L), and the penta-EF-hand domain (PEF(S)) [22]. This domains 
structure of the conventional calpains is defined "classical". Alternatively, "non-classical" 
calpains exclude C2L and/or PEF domains [22]. 
The ubiquitous calpains, play an essential role in all cells and defects in the expression 
of these isoforms may be lethal [22] [24]. Conversely, other forms of the enzymes are 
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involved in more specific cellular functions and their defects may cause tissue-specific 
altered phenotypes [22] [25]. 
The catalytic mechanism of calpain is common to other cysteine-proteases, serine-
proteases and threonine-proteases and depends on three amino acids collectively named 
"catalytic triads"[26]. In calpain, the residue used as a nucleophile is the oxidized sulfur 
of the cysteine. In addition, the basic and acid residues needed for catalysis are provided 
by an histidine and an aspartate, respectively [27]. 
The physiological role of classical calpains is related to extracellular signals 
transduction mediated by changes in the permeability of the plasma membrane to Ca2+ 
or by the mobilization of this ion from intracellular stores. Indeed, the Ca2+ ions trigger 
the structural transitions of these calpains observed during the activation of the enzyme 
[28]. The crystallographic analysis of the enzyme structure and the studies of the kinetics 
of Ca2+ binding have demonstrated that the onset of proteolytic activity appears only 
after a delay. This delay has been attributed to a Ca2+-induced conformational change 
making the active site of the enzyme accessible to the substrate. Furthermore, Ca2+ 
causes the dissociation of the heterodimeric native calpain into its constitutive L- and S-
subunits, resulting in an increased affinity for Ca2+ of the catalytic subunit compared to 
the native form, thereby yielding the active form of the protease [28] [29]. In the 
absence of Ca2+ the amino acid residues of the active site, which are crucial for the 
proteolytic activity, are not correctly positioned with respect to the substrates binding 
site. Hence, the binding of Ca2+ causes an electrostatic switch of the L-subunit 
producing the conformational changes necessary for the correct positioning of the 
catalytic triad [28]. Indeed, the primary event in the activation process corresponds to 
the binding of Ca2+ to eight interacting sites, four in each of the two subunits, localized 
in calmodulin-like regions. Progressive binding of Ca2+ ions is linearly correlated with 
the dissociation of the heterodimeric enzyme, which reaches completion when all the 
Ca2+ binding sites are occupied [29]. 
Exposure to Ca2+ also induces autoproteolysis of classical calpains. In these conditions, 
the 80 kDa calpain subunit, undergoes intramolecular autoproteolysis that, by the 
removal of a peptide from the N-terminus, generate a 75 kDa species with an increased 
affinity for Ca2+. Thus, such autoproteolytic event contributes to make the active site 
accessible to the substrate [29] [30]. An important question in the field of calpain 
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research concerns the remarkable inconsistency of Ca2+ requirement necessary to 
activate the enzyme in vitro and the intracellular availability of this metal ion. Indeed 
although μM concentrations of Ca2+ are sufficient to activate purified calpain-1, the 
physiological amounts of cytosolic Ca2+ are in the range of 50-300 nM [31]. Since in vitro 
experiments have demonstrates that phospholipids, the most abundant type of lipid 
constituents in the cell membranes, lowered the Ca2+ requirement necessary to activate 
the protease, it has been hypothesized that cell microdomains close to the plasma 
membrane could present favorable locations for the calpain activation. It has been also 
proposed that the activation of a limited amount of total calpain, whose localization 
coincides with the spots where cell Ca2+-concentration substantially increases, is 
sufficient to carry-out the calpain-dependent physiological function of a cell [31]. 
Although the isolated 80 kDa catalytic subunit of calpain shows a 2-fold increased 
affinity for Ca2+ than the native heterodimeric form, only the autoproteolyzed 75 kDa 
form of the catalytic subunit shows a 20-fold increased affinity for Ca2+, reaching a Kd 
closer to the physiological Ca2+ concentration [29]. 
An extensive literature suggests that classical calpains participate in a variety of cell 
functions including the remodeling of cytoskeletal/membrane attachments during cell 
fusion and motility, processing of proteins involved in the control of the cell cycle, gene 
expression and apoptotic pathways [31]. Furthermore, over-activation of calpains has 
been linked to a variety of degenerative conditions in the brain and several other tissues. 
Therefore, calpain activation is considered a primary contributor to the onset and 
progression of degenerations in vulnerable populations of neurons and other cell types 
[20]. Particularly, pathological activation of calpain in condition of calcium-overloading 
causes excessive proteolysis and consequently degradation of different substrates crucial 
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2. AIM OF THE WORK 
The aim of this thesis consists in the assessment of the possible biological effects of 
the olive pomace extract purified at high temperature and high pressure (HPTE) and 
containing concentrated olive oil polyphenols. Specifically we have investigated the cell 
response and the underlying biochemical processes modulated by HPTE in conditions 
of altered [Ca2+]i. First we have set up the experimental conditions on human 
neuroblastoma (SK-N-BE) and mouse brain endothelioma (bEnd5) cell lines.  
Subsequently we have used primary cultures of murine cortical neurons as a cell model 
considerably most suitable to investigate the pathological role of calcium in 
neurodegenerative processes.  We have evaluated the specificity of the bioactive 
molecules present in HPTE during cell stimulation with excitotoxic concentrations of 
various agonists, directed toward the different glutamate receptors.  In these conditions 
we have analyzed the activity of HPTE by measuring changes of cell viability and by 
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3. MATERIALS AND METHODS 
3.1. Reagents and antibodies 
Ca2+-ionophore A23187, NMDA, AMPA, glutamate, MK-801 hydrogen maleate 
powder and mouse monoclonal anti-non-erythroid spectrin antibody, were purchased 
from Sigma-Aldrich. ECL SelectTM Western Blotting Detection Reagent was obtained 
from GE Healthcare. Calcium Green™-1 and t-BOC (t-butyloxycarbonyl)-Leu-Met-
CMAC (7-amino-4-chloromethylcoumarin), a fluorogenic calpain substrate, were 
purchased from Molecular Probes (Invitrogen). Mouse monoclonal anti-nNOS antibody 
was purchased from BD Transduction Laboratories. Horseradish peroxidase (HRP)-
linked anti-mouse and anti-rabbit secondary antibodies and Protease and Phosphatase 
Inhibitor Cocktail were purchased from Cell Signaling. Mouse monoclonal anti β-actin 
antibody was from Santa Cruz. 
3.2. Cell culture 
Human neuroblastoma SK-N-BE cells (Interlab Cell Line Collection ICLC, 
HTL96015, Italy) were maintained in continuous culture at 37°C (5 % CO2) with 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% foetal bovine 
serum, 10 U/ml penicillin, 100 μg/ml streptomycin and 2 mM L-glutamine.  
Mouse brain endothelioma bEnd5 cells were kindly provided by L. Riboni 
(Department of Medical Chemistry, Biochemistry and Biotechnology, University of 
Milan, LITA-Segrate, Milan, Italy) and maintained in continuous culture at 37°C (5% 
CO2) with DMEM containing 10% foetal bovine serum, 10 U/ml penicillin, 100 μg/ml 
streptomycin, and 2 mM L-glutamine. All products used for cell culture were purchased 
from Euroclone S.p.A.  
Primary neuron cultures were obtained by the collaboration with Prof. Franco Onofri 
(Department of Experimental Medicine, section of Physiology, University of Genova) 
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and were prepared from cerebral cortices of E18.0 day-old mouse embryos recovered 
from CO2 anaesthetized pregnant C57BL/6J. Briefly, embryos were removed, 
microdissected and brain cortex pieces were dissociated by enzymatic digestion in 
Trypsin 0.25% for 20 min at 37 °C and then triturated with a fire-polished Pasteur 
pipette. Dissociated neurons were plated onto 0.1 mg/ml poly-L-lysine coated cell 
culture supports. Cells were maintained in a culture medium consisting of Neurobasal 
(Invitrogen), supplemented with B-27 (1:50 v/v, Invitrogen), Glutamax (1% v/v, 
Invitrogen), 10 U/ml penicillin, 100 g/ml streptomycin, and kept at 37°C in a 5% CO2 
humidified atmosphere. The 50% medium was changed weekly. No antimitotic medium 
agent was used to control glial proliferation, because application of serum-free medium 
limits the growth of non-neuronal cells. Neurons were allowed to grow functional and 
structural mature networks (approximately 14 days in vitro).  
3.3. Extraction of bioactive molecules from olive pomace 
of Taggiasca cultivar 
HPTE was kindly provided by Prof.ssa Patrizia Perego (Department of civil, chemical 
and enviromental engineering, University of Genova). Bioactive molecules were 
extracted from olive pomace of Taggiasca cultivar by means of a green and non-
conventional extraction technique using a high pressure and temperature (HPTP) 
reactor (model 4560, PARR Instrument Company, Moline, USA). Extractions 
parameters were selected based on previous work [5] [32].  
Particularly, the temperature of the extraction is 180 °C and authors observed that, 
despite the high temperature, no production of 5-hydroxymethylfurfural occurred [5]. 
During the extraction, the pressure inside the reactor reached 25 bar. After extraction, 
the liquid phase rich in biophenols, was separated from the exhausted olive pomace by 
centrifugation at 6.000 ×g for 10 min. Then, the extract of olive pomace, after a 
preliminary concentration by rotary evaporator (Laborota, Heidolph, Germany), was 
submitted to solid phase extraction using a C18 cartridge (Sep-Pak C18 5 mL, Water, 
Milan, Italy) in order to remove proteins or sugars. Briefly, 1 mL of sample was filtered 
in a C18 cartridge after its activation with a solution of H2SO4 5 mM. The cartridge was 
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washed with 5 mL of H2SO4 5 mM, than the adsorbed material was eluted by the 
addition of 5 mL of methanol. Methanol was removed and the material suspended in 
the same solvent used for the HPTE extraction. The HPTE extract was stored at -20°C 
until further analysis. On HPTE extract, total biophenol concentration was determined 
using Folin-Ciocalteu assay and was expressed as mg of caffeic acid equivalents (CAE) 
per mL of solvent (mgCAF/mL). Single phenolic compounds were quantified using 
HPLC methodology using the corresponding phenol standard solutions following the 
methodology described in [32] (see Table 1). Different preparations of HPTE were 
performed, but the method of extraction was the same [32] [33]. 
 
Table 1. Concentration (mg/mL) in total biophenols and single phenolic compounds in 
HPTE after the extraction at high pressure and high temperature. 
Total Biophenols (mgCAE/mL) 
Tyrosol (mg/mL) 
Caffeic acid (mg/mL) 










3.4. Cell viability assay  
Cell viability was measured using the Neutral Red Uptake (NRU) assay, as reported by 
Repetto et al [34]. Briefly, the neutral red uptake assay provides a quantitative estimation 
of the viable cells in a culture. It is based on the ability of viable cells to incorporate 
neutral red dye in the lysosomes. Cells were seeded in 96-well plates and treated for the 
appropriate period. The plates were then incubated for 1 h at 37 °C with a medium 
containing neutral red. The cells were then washed and the dye was extracted in each 
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well with a destaining solution (48% EtOH 1% CH3COOH). The absorbance was 
finally read using a spectrophotometer set at a wavelength of 540 nm [34] 
3.5. Immunoblot analysis 
Murine cortical neurons (3×105), seeded in 35 mm culture dishes and treated as 
described elsewhere, were lysed by sonication in 150 μL of 50 mM Tris/HCl, pH 7.4 
containing 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, and Protease and 
Phosphatase Inhibitor Cocktail diluted 1:100. The lysates were centrifuged at 10.000 ×g 
for 10 minutes at 4 °C, the supernatants were collected, and protein quantification was 
assayed by the method of Lowry. Samples were then heated for 5 minutes at 95°C. 
Proteins (20 g/lane) were separated by SDS/PAGE (8% or 10%) and transferred onto 
nitrocellulose membranes. The nitrocellulose membranes were blocked in 5% non-fat 
dry milk, 0.1% Tween 20 and incubated for 16 h at 4 °C with a primary antibody: anti-
non erythroid spectrin (1:500), anti-nNOS (1:2500), anti--actin (1:1000), anti-phospho-
ERK1/2 (1:1000). Peroxidase-conjugated secondary antibodies (1 h at 22 °C) were anti-
rabbit (1:5000), and anti-mouse (1:5000). Immunoreactive signals were developed using 
ECL SelectTM Western Blotting Detection Reagent (GE Healthcare), acquired and 
quantified using ChemiDoc XRS equipped with the Quantity One Image Software (Bio-
Rad). 
3.6. [Ca2+]i  assay 
2×104 SK-N-BE cells were incubated in 200 μl of HEPES buffer (NaCl 128 mM, KCl 
2.4 mM, MgSO4 1.2 mM, CaCl2 1.2 mM, KH2PO4 1.2 mM, glucose 10 mM, HEPES 10 
mM, pH 7.3–7.4) containing 10 μM Calcium GreenTM-1, AM. After 40 min at 37°C 
cells were washed with HEPES buffer and calcium ionophore A23187 and HPTE were 
added in 100 μl of HEPES buffer. The fluorescence intensity (Excitation 485 nm; 
Emission 535 nm) was measured before (F0) and 3 min after the addition of stimuli (F) 
using the top reading mode in the fluorescence multilabel reader LB 940 Mithras 
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(Berthold Italia). Variations of the fluorescence values were calculated as the difference 
between F and F0. 
Neurons (2.5 × 104, seeded in 96-well microplate) were incubated in HEPES buffer 
containing 10 μM Calcium Green™ -1, AM. After 40 min at 37°C, cells were washed 
twice with HEPES buffer and then exposed to 0.5 mM NMDA, in the absence or in the 
presence of HPTE extract. The fluorescence intensity (Excitation 485 nm; Emission 
535 nm) was measured every 10 seconds for 20 minutes using the top reading mode in 
the fluorescence multilabel reader LB 940 Mithras (Berthold Italia). Variations of the 
fluorescence values were calculated as the difference between each fluorescence value 
recorded and that one measured at time zero. The values obtained were then subtracted 
of the relevant control values. 
3.7. Assay of intracellular Calpain-1 activity 
Human neuroblastoma SK-N-BE cells and murine cortical neurons (2.5 × 104, seeded 
in 96-well microplate) were incubated at 37°C for 20 min with 50 μM t-Boc-Leu-Met-
CMAC fluorogenic calpain substrate in HEPES buffer. Cells were then washed twice 
with HEPES buffer to remove substrate excess, exposed to 0.5 mM NMDA, in the 
absence or in the presence of HPTE extract, and the fluorescence emission was 
monitored every 2 minutes for 1 hour with a Mithras LB 940 plate reader (Berthold 
Technologies). The excitation/emission wavelengths were 355/485 nm, respectively. 
3.8. HPLC and mass spectrometry analysis  
The HPLC and mass spectrometry analysis were performed in collaboration with Prof. 
Gianluca Damonte (Center of Excellence for Biomedical Research, University of 
Genova). Firstly, HPTE was submitted to a pre-treatment: 10 minutes at 37°C, 2 
minutes of vigorous agitation on vortex, and finally 10 minutes at 6.000 ×g to separate 
the insoluble fraction of the extract. After that, 20 l of the supernatant was put 
together with 30 l of water and the resulting 50 l was injected in analytical HPLC 
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Agilent 1260 with manual injection. The operative parameters of the separations are 
reported in Table 2: 
































































































Fractions were collected every 60 seconds, dryed with centrifugal vacuum concentrator 
and conserved at -20 °C. 
After the cell viability test on neurons, only the active fractions was submitted to 
HPLC-MS analysis and the chromatographic separation in HPLC (Agilent 1100 
HPLC) with micro-autosampler was developed using a column Zorbax C18 (pore size 
300 Å, particle size 3,5 ) 0,5 mm (ID) x 150mm (L). In Table 3 we reported the 
analysis parameters: 
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All the parameters were established in order to obtain the best ionization of the 
fractions components. The instrument utilized is a mass spectrometry with orthogonal 
electrospray source (ESI) and high capacity ion trap (Agilent 1100 MSD xct ion trap). 
Analysis was performed in a ion-charged mode control with selected target at 100,000 
and accumulation time of 300 ms. The operative parameters were: capillary voltage: 3,8 
V; nebulizer pressure: 20 psi; drying gas: 8 L/min; dry temperature: 360°C; rolling 
averages: 3, fragmentation Amplitude 0,8 V.  
All the mass spectra have been acquired in Full-scan and in MS-MS modality, breaking 
between the most abundant species under every peak. The acquisition was performed 
on negative and positive ions in the ass range of 50-1200 m. Finally, the HPLC was 
coupled with the mass spectrometry (HPLC-ESI-MS) to value quantitatively the 
compound of interest.  
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4. RESULTS 
4.1. Evaluation of possible cytotoxicity of HPTE on 
human and murine cell lines  
In the first part of this study, in order to define our experimental conditions, we 
analysed the potentially toxic effects of the bioactive molecule(s) contained in HPTE on 
human and mouse cell lines. At this purpose, we performed cell viability experiments on 
human neuroblastoma SK-N-BE cells and murine endothelial bEnd5 cells by means of 
NRU assay. 
Thus, we treated SK-N-BE and bEnd5 cells with increasing concentrations of HPTE 
for 24 hours to establish the maximum non-cytotoxic concentration useful for our 
experiments. 
As shown in Fig.1, the highest HPTE concentration present in the culture medium 
which still maintained 100% of cell viability was 0.05 mg/ml. Indeed, in the presence of 
concentrations higher than 0.05 mg/ml the cells started dying. Similar results were 
obtained with bEnd5 cells. 
 
FIGURE 1: Cell viability of SK-N-BE cells exposed to increasing concentrations of HPTE. SK-
N-BE cells (2×104) were treated with the indicated concentrations of HPTE and cultured for additional 
24 hours. Cell viability was then evaluated by NRU assay. Values represent means ± SEM from three 
independent experiments in triplicate. Similar results were obtained with bEnd5 cells. 
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4.2. Effect of HPTE on cell viability of SK-N-BE and 
bEnd5 cells in condition of altered  [Ca2+]i 
In order to alter intracellular calcium homeostasis, we treated SK-N-BE and bEnd5 
cells with cytotoxic concentrations of calcium ionophore A23187 (I), a mobile ion-
carrier that forms stable complexes with divalent cations allowing their transportation 
across the membranes [35] in the absence or presence of 0.05 mg/ml HPTE. When 
cells were incubated with calcium ionophore alone, we observed a significant reduction 
in cells viability due to the alteration of the intracellular calcium homeostasis. However, 
when the same treatment was performed in the presence of HPTE, a significant 
recovered cells viability was observed, as shown in Fig.2. Similar results were obtained 
with bEnd5 cells. 
 
FIGURE 2: Cell viability of SK-N-BE cells exposed to calcium ionophore (I) A23187 and HPTE. 
(A) SK-N-BE cells (2×104) were treated for 1 h and 15 minutes with 5 μM calcium ionophore A23187 in 
the presence ("I+HPTE") or in the absence ("I") of HPTE 0.05 mg/mL. Cells viability was evaluated by 
NRU assay. Values represent ± SEM from three independent experiments in triplicate. Statistical analysis 
was performed with unpaired t test. **** p<0.0001 for I + HPTE vs I. Similar results were obtained with 
bEnd5 cells. (B) Sub-confluent SK-N-BE cells were treated as specified in A, fixed with ice-cold 100% 
methanol for 15 minutes at 4°C, rinsed three times in PBS for 5 minutes, and then stained for 2-3 minutes 
with 0.1% Toluidine blue. 
These data, obtained on two different cell lines, suggest that HPTE contains bioactive 
molecule(s) capable to counteract the toxic effect of an aberrant calcium influx. 
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4.3. Effect of different olive oil polyphenols on viability of 
SK-N-BE and bEnd5 cells in condition of altered 
[Ca2+]i 
It is well known that EVOO is rich in phenolic compounds that exert several 
biochemical and pharmacological beneficial effects [36] 
To verify if the bioactive molecule(s) present in HPTE, and responsible for the 
protective effect from cell death induced by altered [Ca2+]i could belong to the same 
polyphenols concentrated in HPTE as previously reported [32] we analysed the effect of 
these polyphenols separately on cell viability.  
As shown in Fig.3, when we treated cells with calcium ionophore in the presence of 
the polyphenols tested (tyrosol, oleuropein, apigenin, caffeic acid), we observed that 
none of this molecules were endowed with the ability to protect calcium-induced cell 
death. Similar results were obtained with bEnd5 cells.  
  
FIGURE 3: Cell viability of SK-N-BE cells exposed to calcium ionophore A23187 in the presence 
of olive oil biophenols. SK-N-BE cells (2×104) incubated in the presence (“I+tyrosol”, “I+oleuropein”, 
“I+apigenin”, “I+caffeic acid”) or in the absence (“I”) of 0.01 mg/mL of tyrosol or oleuropein or 
apigenin or caffeic acid, were treated for 1 h and 15 minutes with 5 μM calcium ionophore A23187. Cells 
viability was evaluated by NRU assay and similar results were obtained with bEnd5 cells. Values represent 
means ± SEM from three independent experiments in triplicate. 
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This result suggests that the bioactive molecule(s) responsible for the protective 
activity could belong to polyphenols not yet tested or different types of still unidentified 
molecules. 
4.4. Evaluation of [Ca2+]i and calpain-1 proteolytic activity 
on SK-N-BE cell line 
The results obtained with calcium ionophore and/or HPTE indicate that the bioactive 
molecule(s) were able to counteract calcium induced cell death. In order to better 
elucidate this process, we firstly performed different experiments using a fluorophore 
able to detect the intracellular calcium level and then, we performed different 
experiments using a fluorescent substrate of the calcium-dependent protease calpain-1, 
to monitor its proteolytic activity.  
 
FIGURE 4: Evaluation of [Ca2+]i increase and calpain activity in SKNBE cells exposed to HPTE 
and/or Calcium Ionophore A23187 (I). Notes: A) Calcium GreenTM–loaded cells were pre-treated for 1 
h with 0.01 mg/mL HPTE (“I+HPTE” and “HPTE”) or vehicle (“CTRL” and “I”). The cells were then 
left untreated (“CTRL” and “HPTE”) or exposed to 1 μM I for 3 min (“I” and “I+HPTE”). Data are 
means ± SEM from four independent experiments. Statistical analysis was performed with ANOVA 
followed by Tukey’s post-hoc test. *p<0.05 for I vs CTRL and I+HPTE vs I. B) t-BOC-loaded cells were 
pre-treated as in A) and then left untreated or exposed to 1 μM I for 60 min. Data are means ± SEM 
from three independent experiments. Statistical analysis was performed with ANOVA followed by 
Tukey’s post-hoc test. *p<0.05 for I vs CTRL and **p<0.01 for  I+HPTE vs. I. 
As shown in Fig.4A, treatment of SK-N-BE cells with HPTE maintained the 
intracellular level of the metal ion close to the physiological concentrations (CTRL). 
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We also observed that as a consequence, also the intracellular proteolytic activity of 
calpain-1 (Fig.4B) was maintained at basal level. 
Altogether these results obtained on SK-N-BE cells indicate that HPTE contains 
bioactive molecule(s) able to counteract calcium induced cell death acting through the 
modulation of the [Ca2+]i . 
4.5. Evaluation of possible cytotoxicity of HPTE on 
cortical neurons  
The promising results obtained on cell lines prompted us to further investigate the 
biological activity of HPTE. Thus, we used a primary cell culture of murine cortical 
neurons as a cellular model to test the protective effect of these molecule(s) in condition 
of calcium-mediated excitotoxicity. Indeed, primary neuronal culture from rodents is a 
well-established model to investigate cellular neurobiology in vitro [37]. After 14 days in 
vitro (DIV), we exposed mature neurons to increasing concentrations of HPTE to 
establish the maximum non-cytotoxic concentration to be used in our experiments.  
 
FIGURE 5: Cell viability of cortical neurons exposed to increasing concentration of HPTE. After 
14 DIV, neurons (2×104) were incubated for 24 hours with 0.01, 0.025, 0.04 and 0.05 mg/ml of HPTE. 
Cell viability was evaluated by NRU assay. Values represent means ± SEM from three independent 
experiments in triplicate. 
As shown in Fig.5, we observed that after 24 hours of incubation, the maximum non-
cytotoxic concentration of HPTE which still maintained the highest cell viability was 
 
  29 
0.01 mg/ml. Differently from the cell lines, cortical neurons started dying at 
concentrations immediately higher than 0.01 mg/ml. 
4.6. Effect of HPTE on cell viability of cortical neurons 
exposed to excitotoxic concentration of glutamate  
It is well known that excitotoxicity mediated by glutamate receptors is implicated in 
many neurodegenerative processes [38]. ]Indeed, the vast majority of the excitatory 
neurotransmission in the central nervous system is mediated by vesicular release of 
glutamate, which activates both pre and post synaptic G-protein-coupled metabotropic 
glutamate receptors and ionotropic glutamate receptors [39]. Glutamate receptor 
activation results in an influx of Ca2+ that acts as a second messenger in the regulation of 
neurotransmitter release, synaptic plasticity and gene expression. This change in the 
[Ca2+]i stimulates a number of intracellular events and it can also trigger the cell death 
process [18]. 
Accordingly, we stimulated neurons with a cytotoxic concentration of glutamate in the 
absence or the presence of 0.01 mg/ml HPTE for 24 hours. As shown in Fig.6, when 
we treated neurons with glutamate, HPTE was not able to protect cells from calcium-
induced cell death. This result suggests that the bioactive molecules could be not able to 
protect neurons from death caused by glutamate-mediated excitotoxicty or could act 
through a mechanism that involves only a precise molecular target.  
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FIGURE 6: Cell viability of cortical neurons exposed to glutamate and HPTE. After 14 DIV, 
neurons (2×104) were treated for 24 hours with 300 μM glutamate in the presence ("GLUT+HPTE) or in 
the absence ("GLUT") of 0.01 mg/mL HPTE. Cells viability was evaluated by NRU assay. Values 
represent means ± SEM from seven independent experiments in triplicate. Statistical analysis was 
performed with unpaired t test. ns, not statistically significant. 
4.7. Stimulation of cortical neurons with excitotoxic 
concentration of NMDAR and AMPAR agonists  
To better explain the failure of the bioactive molecule(s) in protecting neurons viability 
in condition of glutamate-mediated excitotoxicity, we decided to stimulate neurons in a 
more selective way by using the agonists of the two major expressed ionotropic 
glutamate receptors: NMDA, a selective agonist of NMDAR, and AMPA (-amino-3-
hydroxy-5-methylisoxazole-4-propionic acid), a selective agonist of AMPAR. In this 
way, we excluded the metabotropic receptors from the stimulation and selected two 
alternative and specific targets able to promote the cell Ca2+ influx. 
First, we stimulated cortical neurons with 300 µM NMDA for 24 hours in the absence 
or in the presence of 0.01 mg/ml of HPTE. As shown in Fig. 7A, the results obtained 
demonstrate that, when neurons were selectively stimulated with NMDA, the bioactive 
molecule(s) contained in HPTE significantly attenuated the calcium influx through the 
receptor, avoiding the alteration of the intracellular calcium homeostasis and preventing 
calcium-induced neuronal death. 
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This result suggests that the bioactive molecule(s) operate through a molecular 
mechanism that involves NMDAR, one of the ionotropic glutamate receptors, as a 
possible specific target.  
 
FIGURE 7: Cell viability of cortical neurons exposed to NMDA or AMPA, and HPTE. After 14 
DIV, neurons (2×104) were treated for 24 hours with 300 μM NMDA (A) or AMPA (B) in the absence 
or in the presence of 0.01 mg/mL HPTE. Cells viability was evaluated by NRU assay. Values represent 
means ± SEM from fifteen independent experiments in triplicate. Statistical analysis was performed with 
unpaired t test. **** p<0.0001; ns, not statistically significant. 
Furthermore, when we stimulated neurons in the same conditions but using AMPA 
instead of NMDA, as shown in Fig.7B, the bioactive molecule(s) were not able to 
prevent cells death.  
Altogether these results demonstrate that the protective activity on neurons viability 
exerted by the bioactive molecule(s) contained in HPTE is related to the specific action 
on the NMDAR-mediated excitotoxicity. Indeed, the treatment with AMPA receptor 
agonist confirmed that when the ion influx occurs through a different ionotropic 
receptor, the protective activity was not detectable.  
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4.8. HPTE preserves the intracellular calcium homeostasis 
following NMDA receptor over-stimulation 
To confirm the specific molecular target of the bioactive molecule(s), we measured the 
intracellular calcium concentration variations by means of CG fluorophore following 
cells exposure to 500 M glutamate, NMDA, and AMPA. The concentrations of the 
stimuli in these experiments were higher than in the cell viability assay because the 
experiments were performed for 20 minutes instead of 24 hours. Moreover, in this 
experiments we used also MK801, a selective non-competitive antagonist of NMDA 
receptor, that completely inhibits the receptor opening.  
As shown in Fig.8, the stimulation of glutamate receptors with the indicated agonists 
resulted in an increase in [Ca2+]i, detectable as delta fluorescence. Interestingly, HPTE 
was able to significantly reduce the delta fluorescence only during NMDA receptor 
stimulation, being ineffective on cells stimulated with either glutamate or AMPA. These 
results confirm that the bioactive molecule(s) could act specifically on the calcium influx 
through NMDA receptor and not on the influx mediated by AMPAR or by the other 
glutamate receptors. Furthermore, the fact that also MK801 failed to block the calcium 
influx promoted by glutamate stimulation, demonstrate that NMDAR is not the only 
responsible of the glutamate-mediated neurons death (see Fig.6).  
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FIGURE 8: Evaluation of [Ca2+]i increase in neurons exposed to excitotoxic stimuli. CG-loaded 
neurons were treated with the indicated stimuli in the absence or in the presence of HPTE. Data are 
means ± SEM from six independent experiments in triplicate, except for NMDA and MK801 (a single 
experiment in triplicate). Statistical analysis was performed with unpaired t test, analysing each 
fluorescence value recorded in the presence of the agonist with its corresponding one recorded in the 
presence of the agonist and HPTE (except for panel C). * p<0.05 
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4.9. Evaluation of different olive oil polyphenols on cortical 
neurons cell viability in condition of calcium-mediated 
excitotoxicity 
 Since we knew that some polyphenols could have a role in the regulation of cell 
calcium concentration and that excitotoxicity is mediated by an aberrant calcium influx 
through glutamate receptors, we replicated the experiments on neurons by using single 
polyphenols, that have been proven to be particularly concentrated in HPTE [32].  
Hence, we treated neurons for 24 hours with an excitotoxic concentration of NMDA 
in the absence or in the presence of oleuropein, tyrosol, apigenin, caffeic acid, or HPTE, 
as a positive control followed by the assay of cell viability. As shown in Fig.9, on 
neurons stimulated with excitotoxic amounts of NMDA, HPTE demonstrated a 
protective activity significantly higher than the olive oil polyphenols did.  
 
FIGURE 9: Cell viability of cortical neurons exposed to NMDA and olive oil polyphenols. 
Neurons (2×104) were incubated with the indicated stimuli for 24 hours. NMDA was used 300 µM; 
polyphenols and HPTE were used 0.01 mg/ml. Values represent ± SEM from three independent 
experiments in triplicate. Statistical analysis was performed with ANOVA followed by Tukey’s post-hoc 
test. * p < 0.05 for NMDA+HPTE vs NMDA+polyphenols. 
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These results suggest that bioactive molecule(s) responsible for the protective activity 
in HPTE could belong to a different class of compounds or could be modified 
derivatives that act in a synergistic way. 
4.10. HPTE prevent the aberrant proteolytic activity of 
calpain-1  
Controlled changes in intracellular calcium concentration are linked to cellular 
functions such as cell proliferation, motility, secretion, and expression of specific genes, 
but prolonged and abnormal alterations of this parameter have been related to a number 
of acute and chronic disease [40]. Since the bioactive molecule(s) were able to 
counteract neuronal death promoted by an intracellular calcium overloading, we 
investigated if the protective effect could also affect the proteolytic activity of the 
calcium-dependent protease calpain-1. 
To this purpose, we loaded neurons with a fluorescent substrate of calpain-1 and 
detected the intracellular proteolytic activity of the enzyme in different conditions as 
shown in Fig.10. Particularly, we detected a basal proteolytic activity of the enzyme in 
untreated cells, whereas in condition of excitotoxicity, the increasing in intracellular 
calcium concentration due to the receptor opening resulted in a significant rise in this 
protease activity. Furthermore, when we treated neurons with NMDA in the presence 
of HPTE, the regulation of the calcium influx exerted by the bioactive molecules 
resulted in the maintenance of the intracellular calcium homeostasis and, as a 
consequence, the aberrant activation of calpain-1 was prevented. 
These results provide further evidence that these molecules are endowed with the 
ability to maintain the intracellular calcium homeostasis protecting neurons from 
different calcium-induced adverse effects, including the aberrant calpain activation.  
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FIGURE 10: Evaluation of calpain-1 activity in neurons exposed to HPTE and/or NMDA. t-
BOC-loaded neurons were treated with the indicated stimuli. Fluorescence was monitored as specified in 
Materials and Methods. Delta fluorescence was calculated subtracting the fluorescence values recorded at 
time zero from those recorded at 30 minutes. Data are means ± SEM from three independent 
experiments in triplicate. Statistical analysis was performed with ANOVA followed by Tukey’s post-hoc 
test. * p<0.05.  
4.11. Protection of calpain-1 substrates from uncontrolled 
degradation following over-stimulation of NMDAR 
To further confirm that the aberrant proteolytic activation of the calcium-dependent 
protease calpain-1 was prevented, we analysed two characteristic substrates of the 
enzyme: II spectrin and nNOS.  
II spectrin is one of the best known and studied substrate of calpain-1 correlated to 
neurodegenerative processes [41] [31], whereas nNOS is related to cell damages 
associated to the abnormal production of NO due to the alteration of calcium 
homeostasis and subsequent abnormal calcium-dependent proteolysis. Indeed, unneed 
activation of calpain, the protease of the Ca2+- dependent proteolytic system, and NO 
synthase are considered the triggering events leading to cell death typical of several 
human neurodegenerative disorders [42]. 
Hence, we analysed the protein levels of these two calpain-1 substrates in our 
experimental conditions. As reported in Fig.11, treatment of neurons with NMDA for 4 
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hours in the presence of 0.01 mg/ml HPTE resulted in a preservation of both calpain-1 
substrates: nNOS and II spectrin. 
 
 
FIGURE 11: Murine cortical neurons treated for 4 hours with NMDA and/or HPTE. A) 
Neurons (3×105) were submitted to immunoblotting following the procedure described in the section 
materials and methods. Antibodies anti II spectrin and anti nNOS were diluted 1:1000 and incubated 
overnight at 4 °C. For each panel a representative blot of  two (II spectrin) or three (nNOS) is shown. 
B) and C) Immunoreactive signals were quantified as described in the section materials and methods. All 
the values reported were normalized vs. -actin signal, and reported as amount relative to control 
(untreated cells). Data are means ± SEM from two (II spectrin) or three (nNOS) independent 
experiments. * p<0.05, according to paired t test. 
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The protection of the native form of II spectrin in condition of altered [Ca2+]i 
represents an evidence that the protective activity of the bioactive molecule(s) occurs 
through a mechanism that maintains the calcium homeostasis preventing the aberrant 
activation of the calpain-1 calcium-dependent protease.  
Furthermore, we have previously demonstrated that the conversion of the native form 
of nNOS into the activated form of 130 kDa is a calcium-dependent event mediated by 
the proteolytic activity of calpain-1 that allows the modulation of NO production [43]. 
Accordingly, in neurons treated with excitotoxic concentration of NMDA in the 
presence of HPTE, we observed the partial preservation of the native form of nNOS 
and the accumulation of the activated 130 kDa nNOS form. These data suggest that the 
proteolytic activity of the calcium-dependent protease calpain-1 occurs in a regulated 
way  preventing its aberrant activation. 
Taken together these results highlight once again that HPTE was able to protect 
neurons from calcium triggered harmful events. 
4.12. Structural characterization of the bioactive molecules 
contained in olive pomace extract 
To identify the molecular nature and structure of the bioactive molecule(s) contained 
in HPTE, we performed several analysis by using High Performance Liquid 
Chromatography (HPLC) and mass spectrometry techniques. 
We fractionated HPTE using HPLC as shown in Fig.12 and we tested the biological 
protective activity of the fractions selected from the range of interest  (17th minute and 
from 20th to 29th minutes), as we previously established.  
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FIGURE 12: Chromathogram of HPTE fractionation. We performed HPLC analysis on HPTE as we 
described in the section material and methods. In this figure, red line is referred to absorbance at 220 nm 
and black line at 254 nm. Vertical black lines are referred to the single fractions collected every 60 
seconds. 
The results presented in Fig.13, indicate that the active fractions were the one eluted 
at the 21st minute and those in the range between 24th and 28th minutes. Successively, we 
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FIGURE 13: Murine cortical neurons viability exposed to NMDA and/or chromatographic 
fractions of HPTE. After 14 DIV, neurons (2×104) were incubated for 24 hours in presence of different 
chromatographic fractions of HPTE (corresponding to the indicated retention time) tested at 0.5 mg/ml 
in the presence (grey bars) or in the absence (white bars) of 300 µM NMDA. Cells viability was evaluated 
by NRU assay.  Values represent means ± SEM from five independent experiments in triplicate. Statistical 
analysis was performed with ANOVA follow by Tukey's post hoc test. **** p<0.0001  vs NMDA (black 
bar). 
In spite of accurate bibliographic and database library research, we have not yet 
succeeded in elucidating the precise molecular structure of these bioactive molecules. 
However, from the study of the fragmentation spectra, we observed that some of the 
molecules identified have a molecular skeleton resembling the one of other molecules 
found in olive pomace extract. Particularly, from the fragmentographic analysis of two 
signal at m/z 407 and m/z 529 we obtained fragmentation spectra compatible with two 
possible molecules: a derivative of Loganin (Fig.14) or of Proanthocyanidins (Fig.15), 
specifically dimers/trimers of Catechin/Epicatechin and/or Gallocatechin/ 
Epigallocatechin. 
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         FIGURE 15: Fragmentation spectra of m/z 529 ion, possible derivative of 
Proanthocyanidins 
4.13. Neurons viability in condition of NMDAR-mediated 
excitotoxicity in presence of epigallocatechin molecule  
On the basis of the data obtained using mass spectrometry techniques, we performed 
different experiments to evaluate neurons viability in condition of NMDAR-mediated 
excitotoxicity in the presence or in the absence of epigallocatechin. This compound is a 
member of the family of proanthocyanidins identified as a possible constituents of the 
bioactive molecule(s) contained in HPTE extract.  
The results shown in Fig.16 indicate that epigallocatechin was able to protects neurons 
from death induced by calcium-mediated excitotoxicity. However, we observed a trend 
of a protective activity less effective than the one exerted by the HPTE.  
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FIGURE 16: Cell viability of cortical neurons exposed to NMDA and epigallocatechin. After 14 
DIV, neurons (2×104) were incubated with the indicated stimuli for 24 hours. Values represent ± SEM 
from six independent experiments in triplicate. Statistical analysis was performed with ANOVA followed 
by Tukey’s post-hoc test. ****p<0.0001 for "NMDA+HPTE"; "NMDA+epigallocatechin" and 
"Epigallocatechin" vs NMDA. 
This data suggests that proanthocyanidins could be the right family of compounds to 
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5. DISCUSSIONS 
In this study we found that bioactive molecules extracted from olive pomace by means 
of a very reproducible high pressure and temperature extraction method prevent the 
death of murine cortical neurons induced by the intracellular Ca2+overloading triggered 
following cell stimulation with NMDA. However, HPTE failed to protect the viability 
of neurons treated with toxic concentrations of glutamate or AMPA. 
In the extract, despite the high extraction temperature (180 °C) no traces of 5-HMF 
were detected by HPLC-MS analysis. The absence of this furanic compound, formed 
during Maillard reaction, could indicate that no degradation reactions occurred during 
the extraction process [44]. This could be due to the presence of high ethanol 
concentrations (50% v/v) and to the absence of oxygen in the reaction vessel.  
Detailed investigation of the effect of HPTE treatment showed that it limited the 
increase in intracellular Ca2+ as well as the over-activation of calpain occurring in 
NMDA-stimulated neuron cells. Altogether, these results demonstrate that HPTE 
selectively reduces the cell Ca2+ influx mediated by NMDAR activation on cells exposed 
to cytotoxic concentrations of the glutamate analogue NMDA, resulting in a significant 
protection of neuronal viability.  
Since calpains undergo activation following calcium dependent cell injury, and the 
uncontrolled activation of calpains is clearly lethal to neurons as well as to other cell 
types [45] [46] [47], we can hypothesize that the preservation of neuronal viability by cell 
treatment with HPTE could depend by a reduced activation of calpain. In this context, 
our results provide evidence that the levels of two natural intracellular calpain substrates, 
nNOS and αII-spectrin, both dramatically decreased in NMDA-treated neuron cells, are 
partially preserved when the cells are stimulated in the presence of HPTE. These data 
confirm that HPTE prevents an aberrant activation of calpain induced by cytotoxic 
NMDA amounts. Of interest, the proteolytic degradation of both calpain substrates is 
directly related with neuronal cell death [48] [49]. This observation suggests that, by 
evaluating the occurrence of a specific pattern of degradation of these calpain targets, it 
could be possible to find a relationship between calpain activity and neuronal cell death. 
Particularly, when we treated neurons with HPTE we could observe not only a recovery 
of the native nNOS, but also a protection of the active 130 kD form produced by 
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calpain against further degradation. This limited proteolytic processing and activation of 
nNOS has been proposed previously to represent a neuroprotective mechanism that 
prevents overproduction of NO [43]. Hence, we hypothesize that one of the molecular 
events involved in the preservation of the neurons viability operated by HPTE consists 
in the regulation of the extent of calpain activation to ensure the accumulation of the 
130 kD form of nNOS. However, further studies are needed for complete insight into 
the protective pathways triggered by the biomolecules contained in HPTE able to 
prevent the onset of excitotoxicity promoted by NMDA. Although our results suggest 
that these bioactive olive pomace-derived molecules act directly on NMDA receptor, 
additional investigations are in progress to characterize this interaction. Moreover, the 
issue we give the highest priority is to identify the molecular nature of the relevant 
bioactive compounds present in HPTE. Our analyses identified two possible molecules: 
one could be a derivative of Loganin and the other one of Proanthocyanidins (specifically 
dimers/trimers of Catechin/Epicatechin and/or Gallocatechin/Epigallocatechin). Since 
it is well known that derivative molecules of Proanthocyanidins play neuroprotective 
effects against glutamate-induced excitotoxicity [50] [18], we tested the potential effect 
of epigallocatechin on neuronal cell viability in conditions of NMDAR over-activation. 
Our preliminary results indicate that this monomer promotes a protective effect on 
neurons similar to that exerted by HPTE. Hence, we hypothesize that the molecules 
contained in HPTE could be derivative of Proanthocyanidins. However, we have planned 
further experiments, carried out by using dimers/trimers of Proanthocyanidins, to establish 
if these compounds actually correspond with the bioactive molecules characterized in 
our study.  
The alteration in [Ca2+]i and the pathological activation of calpain are considered 
among the most important neurodegenerative factors [51] [52]. Considering the 
widespread and devastating effects that derive from excitotoxicity, at present the 
development of effective and reliable approaches to prevent intracellular calcium 
overloading and the consequent aberrant calpain activation represents a major challenge 
to counteract neurodegenerative diseases. In our opinion, the identification in HPTE of 
bioactive molecules endowed with neuroprotective activity on cultures of primary 
neurons, represents a promising starting point for new prophylactic applications and 
therapeutic interventions in these diseases. To obtain a comprehensive information 
about the molecular mechanisms underlying this cell protection from cytotoxicity 
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mediated exclusively by the NMDA glutamate receptor, we are now investigating about 
the physico-chemical, structural and biochemical properties of the relevant molecules 
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